Risk of relapse*
Posts by Omar Dhrif
🚨Pr Xavier Puechal presenting results of the MAINRITSEG trial in #ACR25
⚠️RTX ❌ not superior to AZA in EGPA maintenance
⚡️No difference in 🥇outcome, relapses, GC sparing or AE whatever the ANXA status / severity
⚠️Severe COVID infection RTX > AZA
#EMEUENT
🎤 Dr Caterina Ricordi showcasing :
⚡️Incomplete B-Cell depletion at final infusion of ANCA RTX maintenance treatment 📈 risk of infection
⚡️Younger age & ⬆️ initial serum creatinine 📈 risk of incomplete B-cell depletion
#ACR25 #EMEUENT
Maxime Samson Presenting METOGIA III
⚡️TCZ vs MTX in GC sparing in GCA
🥇MTX did not achieve non inferiority (at wk 76 TCZ 51% vs 39% MTX)
⚡️TCZ > MTX for most 🥈outcomes at wk 52
🚨Watch out for Pneucystosis on High GC doses & MTX
#ACR25 #EMEUNET
📣Thrilled to have had the opportunity to present out work on #LVV strokes in #ACR25
🙏Thank you to @filiere-fai2r.bsky.social for the opportunity
#EMEUNET
#ACR25 SLE guidelines 🔥🔥
Dont miss out ⬇️⬇️
⚡️GCA:
SELECT-GCA III
🥇Sustained remission at W52 UPA15 46.6% UPA7.5 41.2% PBO 29%
No MACE or VTE at W52
🥈 Extension to W104
UPA15 68.6% vs Switch to PBO 28.6%
UPA7.5 70.2% vs Switch to PBO 28.6%
➡️ Switching after year 1 📈 Relapse
#EMEUNET #ACR2025
Year in review Dr Bryant England #ACR2025
⚡️Sjogren’s : Sjogren syndrome❌Sjogren disease✅
⚡️SLE:
1- ACR LN guidelines
➡️CRR is the 🎯
➡️Triple Therapy for the W GC+MPAA+BEL/CNI
2- REGENCY III
CRR at W76: OBI 46% vs PBO 33% 🥇 outcome✅
#EMEUNET #EUMEUNET_Ambassador
#ACR25 Radiology bootcamp 📸
Dr Alyssa Dicosmo on LVV Imaging
⚡️Imaging Pros & Cons ⬇️⬇️
🔊US 🥇in #GCA diagnosis
🧲 MRA + Black Blood to prefer for head & neck imaging
☢️CTA for complications
☢️PET-FDG for early inflammation & systemic evaluation
Hello ! Looking forward to say hi 👋
💡GCA epidemiology is fascinating 🤯
Its incidence varies inexplicably with constitutional & environmental factors🌍
➡️Check out our latest SR & MA as we focus on seasonality & latitude influence on #GCA & how both can be connected
🔗 shorturl.at/MCatV